<!--
  ~ DREIMT Frontend
  ~
  ~  Copyright (C) 2018-2019 - Hugo López-Fernández,
  ~  Daniel González-Peña, Miguel Reboiro-Jato, Kevin Troulé,
  ~  Fátima Al-Sharhour and Gonzalo Gómez-López.
  ~
  ~  This program is free software: you can redistribute it and/or modify
  ~  it under the terms of the GNU General Public License as published by
  ~  the Free Software Foundation, either version 3 of the License, or
  ~  (at your option) any later version.
  ~
  ~  This program is distributed in the hope that it will be useful,
  ~  but WITHOUT ANY WARRANTY; without even the implied warranty of
  ~  MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the
  ~  GNU General Public License for more details.
  ~
  ~  You should have received a copy of the GNU General Public License
  ~  along with this program. If not, see <http://www.gnu.org/licenses/>.
  -->

<div id="main-content">
  <div id="welcome">
    <h2>Welcome to</h2>
    <img src="../../../../../assets/images/logo.svg" alt="DREIMT"/>
    <div>A tool for immune modulation drug prioritization</div>
    <button mat-button (click)="onNavigateToDrugPrioritization()"
            matTooltip="Opens a query panel to get drug prioritizations for a custom signature or geneset.">
      Drug prioritization
    </button>
    <button mat-button (click)="onNavigateToSignaturesComparison()"
            matTooltip="Opens a query panel to find similar signatures or geneset in the database to a custom signature or geneset by calculating the Jaccard index.">
      Signature comparison
    </button>
    <button mat-button (click)="onNavigateToDatabase()"
            matTooltip="Opens the view to explore the database of calculated drug prioritizations.">
      Database
    </button>
  </div>

  <div id="what-is-dreimt">
    <h2>What is DREIMT?</h2>
    <p>
      DREIMT is a bioinformatics tool for <strong>hypothesis generation</strong> and prioritization of
      <strong>drugs</strong> capable of <strong>modulating immune cell</strong> activity from transcriptomics data.
    </p>
    <p *ngIf="stats">
      DREIMT integrates <strong>{{stats.drugCount | number}} drug profiles</strong> from The Library of Network-Based
      Cellular Signatures (LINCS) L1000 data set and <strong>{{stats.signaturesCount | number}} manually curated immune
      gene expression signatures</strong> from multiple resources to generate a <strong>drug-immune signature
      association database</strong>.
    </p>
    <p>
      DREIMT can also prioritize drug associations from user-provided immune signatures.
    </p>
    <p>
      DREIMTdb example queries:
    </p>
    <mat-nav-list role="navigation">
      <mat-list-item classList="small-list-item" *ngFor="let sample of samples.sort(sortSample)"
                     [routerLink]="sample.route" [queryParams]="sample.queryParams">
        <mat-icon matListIcon>search</mat-icon>
        <p mat-line>{{sample.title}}</p>
      </mat-list-item>
    </mat-nav-list>
  </div>

  <div id="home-image-container">
    <h2>DREIMT workflow</h2>
    <p *ngIf="stats">DREIMT integrates <strong>{{stats.drugCount | number}}</strong> consensus drug profiles data set
      and
      <strong>{{stats.signaturesCount | number}}</strong> manually curated immune gene expression signatures to generate
      pairwise drug profile-immune gene expression signature scores. Scores are prioritized to generate a drug
      profile-immune gene expression signature association score (tau). DREIMT uses tau score, FDR false discovery rate)
      and DSS (drug specificity score) to rank and generate hypotheses of drugs able to modulate immune gene expression
      signatures.</p>
    <img src="../../../../../../../assets/images/home-dreimt.png" alt="How it works?">
  </div>

  <div id="disclaimer">
    Disclaimer: this resource is intended for research purposes exclusively. It should not be used for medical or
    professional advice.
    <button mat-button (click)="onShowDataPolicy()">Read our data policy</button>
  </div>
</div>
